Sign in
4

Changes in Ownership

SELLAS Life Sciences Group, Inc. Filed Acc 0001104659-24-006379

CFO acquired 47,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Burns John Thomas CFO 2024-01-22 Grant or award +47,000 101,927 D
Derivatives
Burns John Thomas CFO 2024-01-22 Grant or award · Stock Option (Right to Buy) +75,000 75,000 D
Loading xslF345X05/tm243935-1_4seq1.xml…